PMZ-1620

Sovateltide · Pharmazz, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for PMZ-1620, covering 2023-01-12 to 2023-01-12. Get the full timeline:

Most recent: Clinical Trial Update: PMZ-1620 (Sovateltide) in Mild to Moderate Alzheimer's Disease [Phase 2]